human metapneumovirus vaccine (Valneva SE)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman metapneumovirus vaccine (Valneva SE)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMetapneumovirus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVivalis SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivalis SA
Active IndicationsN/A
Inactive IndicationsMetapneumovirus infections

Other Information

ATC CodeN/A
Related LinksN/A